John N. Lukens
Papers
29
Total Citations
552
H-Index
11
About
John N. Lukens is a leading head and neck oncologist whose research centers on de-intensifying treatment for HPV-related oropharyngeal cancer while preserving excellent oncologic outcomes. His landmark AVOID trial (167 citations) demonstrated that omitting the primary tumor bed from radiation after transoral robotic surgery (TORS) is safe, paving the way for less toxic, personalized therapy. He has also pioneered TORS-assisted endoscopy for identifying occult primary tumors, a major advance for patients presenting with neck metastases of unknown origin. His work comparing quality of life after photon versus proton therapy (48 citations) provides crucial evidence that proton beam scanning reduces normal tissue toxicity. Lukens has further defined patterns of recurrence and salvage outcomes after TORS, establishing benchmarks for lethal recurrence risk and demonstrating that definitive therapy for oligometastatic disease confers a survival advantage. His research spans both HPV-positive and HPV-negative oropharyngeal cancers, offering comprehensive insights into surgical and radiation strategies. With over 400 cumulative citations, Lukens’ contributions are shaping modern, less morbid approaches to oropharyngeal cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10